Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Authors
Keywords
-
Journal
CANCER CELL
Volume 39, Issue 11, Pages 1519-1530.e4
Publisher
Elsevier BV
Online
2021-10-22
DOI
10.1016/j.ccell.2021.09.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
- (2021) Amar Gajjar et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma
- (2021) Rahul Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
- (2019) Alexandra M. Miller et al. NATURE
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
- (2018) Giles W Robinson et al. LANCET ONCOLOGY
- The Utility of Liquid Biopsy in Central Nervous System Malignancies
- (2018) Kathryn S. Nevel et al. Current Oncology Reports
- Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy
- (2018) Eshini Panditharatna et al. CLINICAL CANCER RESEARCH
- Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
- (2018) Florent Mouliere et al. EMBO Molecular Medicine
- Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
- (2017) Joanna Wang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
- (2017) Tina Y. Huang et al. Acta Neuropathologica Communications
- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
- (2015) Yuxuan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer
- (2015) Sobuhi Iqbal et al. SpringerPlus
- MRI Surrogates for Molecular Subgroups of Medulloblastoma
- (2014) S. Perreault et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
- (2013) Vijay Ramaswamy et al. LANCET ONCOLOGY
- Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial
- (2012) Birgitta Lannering et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation